Dr. Ridker was a panelist for the Forum’s discussion on Rethinking Cholesterol.
Dr. Paul M. Ridker is director of the Center for Cardiovascular Disease Prevention, a translational research unit at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS).
Dr. Ridker received his medical degree from HMS. He then completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Ridker is board certified in internal medicine. He provides outpatient services at the Southern Jamaica Plain Health Center, a public-health clinic affiliated with BWH and HMS. His clinical interests include coronary artery disease and the underlying causes and prevention of atherosclerotic disease.
Dr. Ridker is the author of over 500 peer-reviewed publications, 150 reviews and book chapters, and five textbooks related to cardiovascular medicine. Dr. Ridker’s primary research focus has involved inflammatory mediators of heart disease and the molecular and genetic epidemiology of hemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease. Between the years 2000 and 2010, he was among the 10 most often cited researchers in cardiovascular medicine worldwide. Dr. Ridker been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine.